Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness

The SARS-CoV-2 pandemic has produced an unprecedented rush to develop new therapies, ranging from immunizations and antivirals to host-directed therapies to dampen potentially deleterious host inflammatory responses. With a sense of urgency, many groups have proposed repurposing approved drugs for o...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Thomas R., Wurfel, Mark M., Zanoni, Ivan, Ulevitch, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305752/
https://www.ncbi.nlm.nih.gov/pubmed/32574958
http://dx.doi.org/10.1016/j.ebiom.2020.102836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305752/
https://www.ncbi.nlm.nih.gov/pubmed/32574958
http://dx.doi.org/10.1016/j.ebiom.2020.102836

Ejemplares similares